Eastern Maine Dialysis is a medicare approved dialysis facility center in Ellsworth, Maine and it has 11 dialysis stations. It is located in Hancock county at Esrd Satellite Unit, Ellsworth, ME, 04605. You can reach out to the office of Eastern Maine Dialysis at (207) 667-9294. This dialysis clinic is managed and/or owned by Davita. Eastern Maine Dialysis has the following ownership type - Non-Profit. It was first certified by medicare in November, 2012. The medicare id for this facility is 202514 and it accepts patients under medicare ESRD program.
| Name | Eastern Maine Dialysis |
|---|---|
| Location | Esrd Satellite Unit, Ellsworth, Maine |
| No. of Dialysis Stations | 11 |
| Medicare ID | 202514 |
| Managed By | Davita |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| Esrd Satellite Unit, Ellsworth, Maine, 04605 | |
| (207) 667-9294 | |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
| NPI Number | 1922352301 |
| Organization Name | Eastern Maine Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 11 Short St Ellsworth, Maine, 04605 |
| Phone Number | (207) 667-9294 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 66% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 16% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 18% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 64% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 14% |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 70% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 14% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 16% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 81% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 2% | 12% |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 84% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 16% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 78% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 16% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 6% | 12% |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 39 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 26 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 64 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 575 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Eastern Maine Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 64 |
| Hypercalcemia patient months | 575 |
| Patients with Serumphosphor | 68 |
| Patients with Serumphosphor less than 3.5 mg/dL | 5 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 41 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 72 |
| Patient months included in arterial venous fistula and catheter summaries | 508 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 59 |
| Hospitalization Rate in facility | 141.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 252.4 |
| Hospitalization Rate: Lower Confidence Limit | 82.9 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at Eastern Maine Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 19.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 30.8 |
| Readmission Rate: Lower Confidence Limit | 10.3 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Eastern Maine Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| SIR: Upper Confidence Limit | .84 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Eastern Maine Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 49 |
| Transfusion Rate in facility | 3.1 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 107.1 |
| Transfusion Rate: Lower Confidence Limit | .1 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at Eastern Maine Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 251 |
| Mortality Rate in facility | 16.9 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 22.8 |
| Mortality Rate: Lower Confidence Limit | 12.3 |
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago
News Archive
After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.
The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
BioCryst Pharmaceuticals, Inc. presents new results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinically important serum uric acid (sUA) goal of <6 mg/dL on allopurinol alone.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
› Verified 9 days ago